Hot topics in cholangiocarcinoma

por Brandi, Giovanni
Publicado 2019

Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review

por Tavolari, Simona, Brandi, Giovanni
Publicado 2023

Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments

por Brandi, Giovanni, Frega, Giorgio
Publicado 2019

Asbestos and Intrahepatic Cholangiocarcinoma

por Brandi, Giovanni, Tavolari, Simona
Publicado 2020

Novel Targeted Therapies for Advanced Cholangiocarcinoma

por Rizzo, Alessandro, Brandi, Giovanni
Publicado 2021

IDH Inhibitors and Immunotherapy for Biliary Tract Cancer: A Marriage of Convenience?

por Brandi, Giovanni, Rizzo, Alessandro
Publicado 2022

The DNA damage repair (DDR) pathway in biliary tract cancer (BTC): a new Pandora’s box?

por Ricci, Angela Dalia, Rizzo, Alessandro, Brandi, Giovanni
Publicado 2020

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look

por Ricci, Angela Dalia, Rizzo, Alessandro, Brandi, Giovanni
Publicado 2020

PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer

por Rizzo, Alessandro, Ricci, Angela Dalia, Brandi, Giovanni
Publicado 2021

Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update

por Rizzo, Alessandro, Ricci, Angela Dalia, Brandi, Giovanni
Publicado 2022

Neoadjuvant Dovitinib in Early- and Intermediate-Stage Hepatocellular Carcinoma

por Rizzo, Alessandro, Dalia Ricci, Angela, Brandi, Giovanni
Publicado 2022

Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention

por Colussi, Dora, Brandi, Giovanni, Bazzoli, Franco, Ricciardiello, Luigi
Publicado 2013

The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?

por Brandi, Giovanni, Turroni, Silvia, McAllister, Florencia, Frega, Giorgio
Publicado 2021

Improvements in Systemic Therapies for Advanced Malignant Mesothelioma

por Deiana, Chiara, Fabbri, Francesca, Tavolari, Simona, Palloni, Andrea, Brandi, Giovanni
Publicado 2023

Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies

por Brandi, Giovanni, Farioli, Andrea, Astolfi, Annalisa, Biasco, Guido, Tavolari, Simona
Publicado 2015

Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link

por Brandi, Giovanni, Straif, Kurt, Mandrioli, Daniele, Curti, Stefania, Mattioli, Stefano, Tavolari, Simona
Publicado 2022

Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer

por Garajová, Ingrid, Ferracin, Manuela, Porcellini, Elisa, Palloni, Andrea, Abbati, Francesca, Biasco, Guido, Brandi, Giovanni
Publicado 2017

Immune-Based Combinations versus Sorafenib as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Meta-Analysis

por Rizzo, Alessandro, Ricci, Angela Dalia, Fanizzi, Annarita, Massafra, Raffaella, De Luca, Raffaele, Brandi, Giovanni
Publicado 2023

Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue

por Brandi, Giovanni, Deiana, Chiara, Galvani, Linda, Palloni, Andrea, Ricci, Angela Dalia, Rizzo, Alessandro, Tavolari, Simona
Publicado 2023

Nanotechnology-Related Environment, Health, and Safety Research

por Brandi, Giovanni, Nobili, Elisabetta, Di Girolamo, Stefania, Grazi, Gianluca, Fiorentino, Michelangelo, Golfieri, Rita, Biasco, Guido
Publicado 2009